PHARM PACK

THE NEW GENERATION OF MEDICINES BASED ON DNA

In 1994, for the development, production and sale of new generation medicines based on the main component of a living cell, the DNA molecule, a specialized enterprise was established - CJSC "FP" Technomedservice ", which later laid the foundation for the group of companies of research and production campaigns Farmpack and Immunnolex. Our Holding , one of the few in Russia that carries out scientific development, a full production cycle from substances to finished drugs and their distribution.Raw materials for the production of the substance are purchased in Russia, and all packaging materials are purchased from the factories of leading European manufacturers.

Promotion and distribution of drugs are provided by the company "PharmPack", established in 2005. Effective promotion of products requires close cooperation between of the Holding Company " PharmPack " with federal and regional research institutions, scientific medical community in the person of the main medical experts of the Russian Federation, Ministry of Health, and the regional Department of Health. Among them: N.V. Sklifosovsky Research Institute of Emergency Medicine, D.I. Ivanovsky Institute of Virology Russian Academy of Medical Sciences, N.N. Blokhin Russian Cancer Research Center, S. Fyodorov Eye Microsurgery Federal State Institution, S.M. Kirov Military Medical Academy, North-Western State Medical University named after I.I. Mechnikov, Voronezh State Medical University named after N.N. Burdenko, N.P.Ogarev Mordovia State University, Nizhny Novgorod, Tver, Samara, Chelyabinsk State Medical Academy and others.

Our Research and Production Holding annually increases production of the drug: in 10 years of existence the company relise of finished product increased 150 times. The advent of a separate companies "PharmPack ", which engaged in promotion of products, had result of many times increase the effectiveness of sales. Recently growing interest to the product of the Holding Company evinces other countries the distributors. Holding Drugs are registered in Kazakhstan, Ukraine, Belarus, Georgia. The interest in promoting Derinat to market their countries evinces pharmaceutical companies from Slovakia, Yugoslavia, Czech Republic, Bulgaria, and India.

Products of our Holding were repeatedly awarded prestigious diplomas and prizes. In 1997, the Derinat drug was declared the "medicine of Year" by Russian Biographical Institute. In 2000 the company became a laureate of the contest "Enterprise of the 21st century". The company is an official partner of the Kremlin providers Guild has grateful to the President of the Russian Federation, for his great contribution to the establishment of the domestic economy. One of the latest awards – is International Prize "Profession - Life", for achievements in the field of medical production.